IRF7 (interferon regulatory factor 7) is a master transcriptional regulator essential for type I interferon (IFN-α and IFN-β) production and antiviral immune responses 1. The protein functions by binding to interferon-stimulated response elements (ISRE) in promoters of type I IFN genes and IFN-stimulated genes, regulating their transcription 2. IRF7 exists in an inactive cytoplasmic form in uninfected cells but becomes activated through phosphorylation by kinases following viral infection or TLR signaling, leading to dimerization and nuclear translocation where it initiates transcription 1. The protein operates through both MyD88-dependent and MyD88-independent pathways, with particular importance in the TLR3-IRF7 circuit for antiviral immunity 2. Disease relevance is significant, as loss-of-function variants in the TLR3-IRF7 pathway have been identified in patients with life-threatening COVID-19 pneumonia, demonstrating its critical role in defending against SARS-CoV-2 infection 2. Beyond antiviral responses, IRF7 also contributes to autoimmune processes and can promote inflammatory responses in conditions like chr11 prostatitis through regulation of metabolic pathways 3. The MDA5/MAVS/IRF7 pathway also represents a potential therapeutic target in cancer treatment 4.